+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Embolization Particle Market by Product Type, Application, End-User, Material, Size - Global Forecast 2025-2030- Product Image
Embolization Particle Market by Product Type, Application, End-User, Material, Size - Global Forecast 2025-2030- Product Image
Sale

Embolization Particle Market by Product Type, Application, End-User, Material, Size - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6015269
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Embolization Particle Market grew from USD 1.60 billion in 2023 to USD 1.79 billion in 2024. It is expected to continue growing at a CAGR of 11.21%, reaching USD 3.37 billion by 2030.

Embolization particles are specialized materials used in minimally invasive procedures to block blood flow to specific areas, typically for treating tumors, abnormal blood vessels, or controlling bleeding. The necessity of embolization particles arises from their ability to offer targeted therapeutic interventions that preserve healthy tissue while effectively treating the affected area. They are prominently utilized in interventional radiology, oncology, and vascular surgeries. End-use scope spans hospitals, specialty clinics, and academic research institutions, given their involvement in various medical procedures. Market growth is significantly influenced by the rising prevalence of cancer and vascular diseases, technological advancements in embolization techniques, and increased preference for minimally invasive surgeries. Moreover, expanding healthcare infrastructure in emerging economies and increased investment in healthcare innovation serve as potential opportunities. However, growth is challenged by factors like regulatory constraints, potential side effects, and high costs associated with advanced embolization procedures. Despite these challenges, there is potential for remarkable innovation in developing biodegradable and drug-eluting embolization particles, which could enhance patient outcomes and reduce complications. Research and development focused on personalized medicine and the integration of artificial intelligence for better procedural precision are promising avenues for business expansion. The current market is competitive yet promising, with key players investing in R&D for advancing product offerings. Companies should focus on strategic partnerships and collaborations to enhance their technological capabilities and broaden their market presence. Innovation in enhancing particle material properties for better compatibility and effectiveness could set the pace for future advancements. Additionally, fostering strong distribution networks to increase accessibility in emerging markets represents a worthwhile consideration for stakeholders aiming for comprehensive market coverage and sustained growth.

Understanding Market Dynamics in the Embolization Particle Market

The Embolization Particle Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Technological integration with imaging modalities improves precision and efficacy of embolization procedures
    • Enhanced training programs for healthcare professionals increase proficiency in using embolization technologies
    • Patient-centric approaches and customized treatment plans gain prominence in embolization practices
  • Market Restraints
    • High cost of embolization procedures and particles
  • Market Opportunities
    • Increasing demand for minimally invasive procedures to drive growth in embolization particle market
    • Technological advancements and innovation leading to superior performance and new applications of embolization particles
    • Government and private sector investments boosting research and development in embolization particle technologies
  • Market Challenges
    • Complications and risks associated with embolization

Exploring Porter’s Five Forces for the Embolization Particle Market

Porter’s Five Forces framework further strengthens the insights of the Embolization Particle Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Embolization Particle Market

External macro-environmental factors deeply influence the performance of the Embolization Particle Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Embolization Particle Market

The Embolization Particle Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Embolization Particle Market

The Embolization Particle Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Embolization Particle Market

The Embolization Particle Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolization Particle Market, highlighting leading vendors and their innovative profiles. These include ABK Biomedical, Bellostent, Biocompatibles International plc, Boston Scientific Corporation, BTG plc, Cook Medical, EndoShape, Guerbet Group, Hanger Inc., Imbiotechnologies, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Merit Medical Systems, Penumbra Inc., Sequent Medical, Sirtex Medical, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Embolization Particle Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Drug-Eluting Beads
    • Microspheres
    • PVA Particles
    • Radioembolization Particles
    • Tris-Acryl Gelatin Particles
  • Application
    • Neurology
    • Oncology
    • Peripheral Vascular Disease
    • Urology
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Research and Academic Institutes
    • Specialty Clinics
  • Material
    • Acrylic Polymers
    • Gelatin
    • Polyvinyl Alcohol (PVA)
  • Size
    • 100-300 Microns
    • 300-500 Microns
    • 500-700 Microns
    • 700-900 Microns
    • 900 Microns and Above
    • Less Than 100 Microns
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Technological integration with imaging modalities improves precision and efficacy of embolization procedures
5.1.1.2. Enhanced training programs for healthcare professionals increase proficiency in using embolization technologies
5.1.1.3. Patient-centric approaches and customized treatment plans gain prominence in embolization practices
5.1.2. Restraints
5.1.2.1. High cost of embolization procedures and particles
5.1.3. Opportunities
5.1.3.1. Increasing demand for minimally invasive procedures to drive growth in embolization particle market
5.1.3.2. Technological advancements and innovation leading to superior performance and new applications of embolization particles
5.1.3.3. Government and private sector investments boosting research and development in embolization particle technologies
5.1.4. Challenges
5.1.4.1. Complications and risks associated with embolization
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Embolization Particle Market, by Product Type
6.1. Introduction
6.2. Drug-Eluting Beads
6.3. Microspheres
6.4. PVA Particles
6.5. Radioembolization Particles
6.6. Tris-Acryl Gelatin Particles

7. Embolization Particle Market, by Application
7.1. Introduction
7.2. Neurology
7.3. Oncology
7.4. Peripheral Vascular Disease
7.5. Urology

8. Embolization Particle Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Research and Academic Institutes
8.5. Specialty Clinics

9. Embolization Particle Market, by Material
9.1. Introduction
9.2. Acrylic Polymers
9.3. Gelatin
9.4. Polyvinyl Alcohol (PVA)

10. Embolization Particle Market, by Size
10.1. Introduction
10.2. 100-300 Microns
10.3. 300-500 Microns
10.4. 500-700 Microns
10.5. 700-900 Microns
10.6. 900 Microns and Above
10.7. Less Than 100 Microns

11. Americas Embolization Particle Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Embolization Particle Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Embolization Particle Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation


List of Figures
FIGURE 1. EMBOLIZATION PARTICLE MARKET RESEARCH PROCESS
FIGURE 2. EMBOLIZATION PARTICLE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2023


List of Tables
TABLE 1. EMBOLIZATION PARTICLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. EMBOLIZATION PARTICLE MARKET DYNAMICS
TABLE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PVA PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY RADIOEMBOLIZATION PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TRIS-ACRYL GELATIN PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 100-300 MICRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 300-500 MICRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 500-700 MICRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 700-900 MICRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 900 MICRONS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LESS THAN 100 MICRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 50. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 59. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 77. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 82. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 86. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 92. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 101. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 106. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 111. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 116. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 121. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 122. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 126. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 138. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 142. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 147. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 148. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 152. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 157. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 162. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 167. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 168. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 172. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 187. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 188. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 192. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 193. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 197. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 217. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 232. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 243. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 244. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Embolization Particle Market, which are profiled in this report, include:
  • ABK Biomedical
  • Bellostent
  • Biocompatibles International plc
  • Boston Scientific Corporation
  • BTG plc
  • Cook Medical
  • EndoShape
  • Guerbet Group
  • Hanger Inc.
  • Imbiotechnologies
  • Johnson & Johnson
  • Kaneka Corporation
  • Medtronic plc
  • Merit Medical Systems
  • Penumbra Inc.
  • Sequent Medical
  • Sirtex Medical
  • Stryker Corporation
  • Terumo Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.37 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

PVA Foam Embolization Particle Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

PVA Foam Embolization Particle Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 88 Pages
  • Global
From
Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 - Product Image

Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

  • Report
  • Global
From
Vascular Embolization Global Market Report 2024 - Product Image

Vascular Embolization Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Oncology Embolization Agents Market Snapshot - Product Image

Oncology Embolization Agents Market Snapshot

  • Report
  • 10 Pages
  • Global
From
Vascular Embolization Market by Embolization Technique, Application, End-User - Global Forecast 2025-2030 - Product Image

Vascular Embolization Market by Embolization Technique, Application, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.